Events

This webinar series explores two powerful, complementary disciplines that CDMOs leverage to tackle these challenges head-on. First, we examine the solid-state domain, exploring how targeted crystallization development can directly address purification, filtration, stability, and processability challenges from lab scale through commercialization. Then, we see how chromatographic modeling tools in combination with innovative techniques like “fraction...

CHO expression continues to evolve, and recent advances are reshaping how quickly and efficiently high-performing cell lines are developed. In this webinar, experts explore the latest innovations in the GS® Expression System, highlighting how advanced vector design, stronger selection stringency, and enhanced promoter control are driving higher titers, more stable pools, and faster timelines from...

Bringing innovative antibody therapeutics to market quickly requires more than upstream efficiency. It demands adaptable and robust downstream purification strategies. As novel mAb formats increase in complexity, purification challenges grow. Achieving required purity and yield often extends beyond traditional 2–3 step platform processes, requiring expanded chromatography options and optimized buffer systems. In this webinar, we...

Immune checkpoint inhibitors have transformed cancer treatment, but response rates remain limited, and immune-related toxicities continue to pose challenges. Gene editing of therapeutic T cells offers a promising path to help enhance specificity and safety by directly modulating checkpoint expression. In this webinar, we explore how gene-edited T cells targeting PD-1 and TIGIT can improve...

Technology transfer to a CDMO is rarely as simple as handing over a data package. From documentation gaps and equipment differences to method variability and global standards, many programs encounter avoidable risks that can derail timelines and increase cost. In this Outsourced Pharma Live session, industry experts share practical strategies to help sponsors better prepare...

In this webinar, Lonza experts share insights from 70+ bispecific programs, revealing the most common early‑stage risks across analytical development, downstream purification, and drug product formulation. You’ll learn where challenges typically emerge before IND, how early decisions shape CMC readiness, and when to rely on platform approaches versus molecule‑specific strategies to avoid costly delays. Key...